stoxline Quote Chart Rank Option Currency Glossary
Universe Pharmaceuticals INC (UPC)
1.15  0.13 (12.75%)    12-06 15:59
Open: 1.01
High: 1.22
Volume: 68,066
Pre. Close: 1.02
Low: 0.99
Market Cap: 4(M)
Technical analysis
2023-12-06 4:24:47 PM
Short term     
Mid term     
Targets 6-month :  1.67 1-year :  1.95
Resists First :  1.42 Second :  1.67
Pivot price 1
Supports First :  1.04 Second :  0.8
MAs MA(5) :  1.01 MA(20) :  1.02
MA(100) :  1.32 MA(250) :  3.31
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  48.6 D(3) :  36.9
RSI RSI(14): 54.8
52-week High :  12.47 Low :  0.75
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ UPC ] has closed below upper band by 13.0%. Bollinger Bands are 11.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.22 - 1.23 1.23 - 1.23
Low: 0.98 - 0.98 0.98 - 0.99
Close: 1.14 - 1.15 1.15 - 1.16
Company Description

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Headline News

Thu, 12 Oct 2023
Healthcare Stocks on the Move Thursday: OPGN, EDSA, UPC, WINT, TPST, PHIO, PMVP, PROK - InvestorsObserver

Thu, 27 Jul 2023
Universe Pharmaceuticals INC Announces Share Consolidation - Yahoo Finance

Fri, 16 Jun 2023
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.32% By - Canada

Fri, 16 Jun 2023
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.32% By -

Wed, 14 Dec 2022
SEC Charges Atlas Trading in $114 Million Penny Stock (GTTN, SURF, UPC) Fraud - Bloomberg

Fri, 01 Oct 2021
Cingulate Stock (NASDAQ:CING), Quotes and News Summary - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers—Specialty & Generic
Shares Out 4 (M)
Shares Float 2 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 25 (K)
Stock Financials
EPS -3.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 13
Profit Margin -32.5 %
Operating Margin 0.8 %
Return on Assets (ttm) -8.9 %
Return on Equity (ttm) -20.7 %
Qtrly Rev. Growth -23.8 %
Gross Profit (p.s.) 6.04
Sales Per Share 9.5
EBITDA (p.s.) -2.63
Qtrly Earnings Growth 0 %
Operating Cash Flow -3 (M)
Levered Free Cash Flow 4 (M)
Stock Valuations
PE Ratio -0.38
PEG Ratio 0
Price to Book value 0.08
Price to Sales 0.12
Price to Cash Flow -1.59
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android